Karen Akinsanya - President of R&D, Therapeutics at Schrodinger, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President of R&D, Therapeutics
Stock Symbol
SDGR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Karen Akinsanya since 11/21/2023

Holdings reported by Karen Akinsanya for Schrodinger, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 120K Mar 4, 2024 Direct Common Stock

Transactions reported by Karen Akinsanya for Schrodinger, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.